SOCS3 - Suppressor of Cytokine Signaling 3

Migration, Crosslink

📖

SOCS3 - Suppressor of Cytokine Signaling 3

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-socs3

📖 Wiki Page

gene1237 wordssynced 2026-04-02

SOCS3 - Suppressor of Cytokine Signaling 3

<div class="infobox infobox-gene">
<h3>SOCS3</h3>
<table>
<tr><td><strong>Full Name</strong></td><td>Suppressor of Cytokine Signaling 3</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SOCS3 (CIS3, SSI3)</td></tr> [@babon2014]
<tr><td><strong>Chromosomal Location</strong></td><td>17q25.3</td></tr> [@croker2003]
<tr><td><strong>NCBI Gene ID</strong></td><td>[9021](https://www.ncbi.nlm.nih.gov/gene/9021)</td></tr> [@okada2006]
<tr><td><strong>OMIM</strong></td><td>[604176](https://omim.org/entry/604176)</td></tr> [@reichenbach2019]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000184557](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184557)</td></tr> [@qin2012a]
<tr><td><strong>UniProt (Protein)</strong></td><td>[O14543](https://www.uniprot.org/uniprot/O14543)</td></tr> [@sun2021]
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Multiple Sclerosis</td></tr>
</table>
</div>

Overview

...

SOCS3 - Suppressor of Cytokine Signaling 3

<div class="infobox infobox-gene">
<h3>SOCS3</h3>
<table>
<tr><td><strong>Full Name</strong></td><td>Suppressor of Cytokine Signaling 3</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SOCS3 (CIS3, SSI3)</td></tr> [@babon2014]
<tr><td><strong>Chromosomal Location</strong></td><td>17q25.3</td></tr> [@croker2003]
<tr><td><strong>NCBI Gene ID</strong></td><td>[9021](https://www.ncbi.nlm.nih.gov/gene/9021)</td></tr> [@okada2006]
<tr><td><strong>OMIM</strong></td><td>[604176](https://omim.org/entry/604176)</td></tr> [@reichenbach2019]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000184557](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184557)</td></tr> [@qin2012a]
<tr><td><strong>UniProt (Protein)</strong></td><td>[O14543](https://www.uniprot.org/uniprot/O14543)</td></tr> [@sun2021]
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Multiple Sclerosis</td></tr>
</table>
</div>

Overview

Mermaid diagram (expand to render)

SOCS3 (Suppressor of Cytokine Signaling 3) encodes a key negative feedback regulator of the [JAK-STAT signaling pathway](/mechanisms/jak-stat-pathway), one of the primary intracellular signaling cascades mediating cytokine and growth factor responses. SOCS3 is rapidly induced by inflammatory stimuli and functions as a molecular brake on cytokine-driven signaling, preventing excessive inflammation. In the central nervous system, SOCS3 plays critical roles in regulating microglial activation, astrocyte reactivity, neuronal survival, and axonal regeneration. Dysregulation of SOCS3 expression has been implicated in the chronic neuroinflammation that drives [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and multiple sclerosis.

Gene Structure and Expression

SOCS3 is an intronless gene located on chromosome 17q25.3, encoding a 225 amino acid protein. The single-exon structure enables rapid transcriptional induction (within 30-60 minutes of cytokine stimulation), which is essential for its role as an immediate-early feedback inhibitor. Transcription is driven by [STAT3](/genes/stat3), [STAT1](/genes/stat1), and [NF-κB](/mechanisms/nf-kb-pathway), creating classic negative feedback loops. Promoter methylation by [DNMT1](/genes/dnmt1)/[DNMT3A](/genes/dnmt3a) can silence SOCS3, leading to unopposed JAK-STAT signaling.

In the brain, SOCS3 is constitutively expressed at low levels in [neurons](/entities/neurons), with inducible expression in [microglia](/cell-types/microglia-neuroinflammation), [astrocytes](/entities/astrocytes), and oligodendrocytes upon inflammatory activation. Microglial SOCS3 is the most dynamically regulated, showing rapid induction following exposure to [LPS](/mechanisms/tlr-signaling), [IL-6](/genes/il6), [IFN-γ](/genes/ifng), and other inflammatory mediators. The [Allen Brain Atlas](https://human.brain-map.org/) shows broad neuronal expression with enrichment in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex).

Protein Function and Mechanism

Domain Architecture

SOCS3 contains three functional domains:

KIR (Kinase Inhibitory Region): N-terminal pseudosubstrate domain that directly inhibits [JAK](/genes/jak1) kinase activity by occupying the substrate-binding groove

SH2 (Src Homology 2) domain: Central phosphotyrosine-binding domain that targets SOCS3 to specific phosphorylated receptor motifs (gp130 pY757, LIFR, LEPR, EPOR)

SOCS box: C-terminal domain that recruits Elongin B/C-Cullin5-RBX2 E3 ubiquitin ligase complex, targeting bound JAK kinases and receptors for proteasomal degradation

Mechanism of JAK-STAT Inhibition

SOCS3 employs a dual inhibitory mechanism:

Direct JAK inhibition: The KIR domain binds the substrate-binding groove of [JAK1](/genes/jak1), [JAK2](/genes/jak2), and [TYK2](/genes/tyk2), acting as a pseudosubstrate to block kinase activity. This is a rapid mechanism operating within minutes of SOCS3 induction

Ubiquitin-mediated degradation: The SOCS box recruits the CUL5-based E3 ligase complex, targeting associated JAK kinases and cytokine receptor complexes for K48-linked polyubiquitination and proteasomal degradation. This provides sustained signal termination

Specificity and Selectivity

SOCS3 preferentially inhibits signaling through:

IL-6 family cytokines (via gp130): IL-6, LIF, CNTF, oncostatin M, cardiotrophin-1
IL-10: Limits anti-inflammatory IL-10 signaling duration
Leptin receptor: Contributes to leptin resistance
G-CSF/EPO receptors: Regulates hematopoietic cytokine signaling

SOCS3 does NOT effectively inhibit [IFN-γ](/genes/ifng) signaling (which is regulated by [SOCS1](/genes/socs1)), creating pathway-specific regulation of inflammatory responses.

Disease Associations

Alzheimer's Disease

SOCS3 dysregulation contributes to the chronic neuroinflammation characteristic of [AD](/diseases/alzheimers-disease):

Promoter hypermethylation: SOCS3 promoter is hypermethylated in AD microglia, leading to reduced expression and unopposed JAK-STAT3 activation. This drives a chronically activated microglial phenotype that sustains neuroinflammation
Aβ-driven inflammation: [Amyloid-beta](/proteins/amyloid-beta) oligomers activate JAK-STAT3 signaling in microglia and astrocytes. Inadequate SOCS3 feedback allows sustained IL-6, TNF-α, and complement production
Astrocyte reactivity: SOCS3 deletion in astrocytes ([GFAP](/entities/gfap)-Cre;Socs3fl/fl) leads to exaggerated STAT3-dependent reactive astrogliosis and accelerated amyloid plaque-associated inflammation
Therapeutic potential: Restoring SOCS3 expression through demethylating agents or viral vector delivery reduces neuroinflammation in AD mouse models

Parkinson's Disease

Microglial activation: Substantia nigra microglia in PD show reduced SOCS3 with elevated STAT3 phosphorylation, indicating impaired feedback inhibition
Dopaminergic neuron protection: Neuronal SOCS3 protects dopaminergic neurons from cytokine-induced death. SOCS3 overexpression in the SNpc attenuates MPTP-induced neurodegeneration
α-Synuclein-driven inflammation: Extracellular [α-synuclein](/proteins/alpha-synuclein) activates microglial JAK-STAT signaling; SOCS3 is induced but insufficient to fully resolve the response in the context of continuous α-synuclein release

Multiple Sclerosis

SOCS3 is a master regulator of Th17 cell differentiation: SOCS3 deletion enhances [STAT3](/genes/stat3)-driven [IL-17](/genes/il17a) production, exacerbating experimental autoimmune encephalomyelitis (EAE)
Oligodendrocyte precursor cell (OPC) SOCS3 limits [CNTF](/genes/cntf)-driven remyelination, presenting a therapeutic target for enhancing myelin repair

ALS

Spinal cord microglia in [ALS](/diseases/amyotrophic-lateral-sclerosis) show progressive loss of SOCS3 expression as disease advances
[SOD1](/entities/sod1) mutant motor neurons have impaired SOCS3 induction, rendering them more susceptible to cytokine-mediated death
SOCS3 deletion accelerates disease progression in SOD1-G93A mice

Axonal Regeneration (Double-Edged Sword)

Paradoxically, SOCS3 deletion promotes CNS axonal regeneration:

Conditional SOCS3 knockout in retinal ganglion cells enables robust optic nerve regeneration through sustained STAT3 activation
This presents a therapeutic dilemma: SOCS3 inhibition could promote axon regrowth but exacerbate neuroinflammation

Common Variants

| Variant | rsID | Consequence | Clinical Significance |
|---------|------|-------------|----------------------|
| -920C>A | rs4969168 | Promoter | Altered transcription; association with MS susceptibility |
| -1044C>A | rs4969170 | Promoter | Modified STAT3 binding site; inflammatory disease associations |
| Promoter CpG methylation | - | Epigenetic | Silencing in AD microglia; correlates with chronic neuroinflammation |

Therapeutic Implications

Restoring SOCS3 in Neurodegeneration

Demethylating agents: Low-dose decitabine or 5-azacytidine to restore SOCS3 expression in hypermethylated microglia
AAV-SOCS3 delivery: Viral vector-mediated SOCS3 expression in microglia/astrocytes to dampen chronic neuroinflammation
SOCS3-mimetic peptides: Cell-permeable KIR domain peptides that directly inhibit JAK activity
JAK inhibitors as SOCS3 mimetics: Tofacitinib, baricitinib (approved JAK inhibitors) functionally replicate SOCS3 action; [blood-brain barrier](/entities/blood-brain-barrier) penetration limits CNS utility

SOCS3 Inhibition for Regeneration

Transient, localized SOCS3 suppression (antisense oligonucleotides) to promote axonal regeneration in spinal cord injury and optic nerve damage
Must be temporally controlled to avoid chronic inflammatory consequences

Biomarker Applications

CSF SOCS3 protein levels or methylation status as biomarkers of neuroinflammatory activity
SOCS3/STAT3 ratio in peripheral monocytes as a proxy for CNS inflammatory state

Expression Profile

Microglia: Low basal, rapidly induced (30-60 min) by IL-6, LPS, IFN-γ; reduced in disease
Astrocytes: Inducible; regulates reactive astrogliosis magnitude
Neurons: Constitutive low expression; protects from cytokine-mediated death
Oligodendrocytes: Limits CNTF-driven differentiation and remyelination
Peripheral: Broadly expressed in immune cells, liver, adipose tissue

External Links

[NCBI Gene: SOCS3](https://www.ncbi.nlm.nih.gov/gene/9021)
[UniProt: O14543](https://www.uniprot.org/uniprot/O14543)
[GeneCards: SOCS3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SOCS3)
[OMIM: 604176](https://omim.org/entry/604176)
[Allen Brain Atlas: SOCS3](https://human.brain-map.org/)

References

[Yoshimura A et al., SOCS proteins, cytokine signalling and immune regulation (2007) (2007)](https://doi.org/10.1038/nri2093)

[Baker BJ et al., SOCS1 and SOCS3 in the control of CNS immunity (2009) (2009)](https://doi.org/10.1016/j.tins.2009.07.001)

[Qin H et al., Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation (2012) (2012)](https://doi.org/10.1073/pnas.1209743109)

[Smith PD et al., SOCS3 deletion promotes optic nerve regeneration in vivo (2009) (2009)](https://doi.org/10.1016/j.neuron.2009.09.016)

[Babon JJ et al., The molecular regulation of Janus kinase (JAK) activation (2014) (2014)](https://doi.org/10.1042/BJ20140712)

[Croker BA et al., SOCS3 negatively regulates IL-6 signaling in vivo (2003) (2003)](https://doi.org/10.1038/ni931)

[Okada S et al., Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury (2006) (2006)](https://doi.org/10.1038/nm1425)

[Reichenbach N et al., Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model (2019) (2019)](https://doi.org/10.15252/emmm.201809665)

[Qin H et al., SOCS3 deficiency promotes M1 macrophage polarization and inflammation (2012) (2012)](https://doi.org/10.4049/jimmunol.1201168)

[Sun KH et al., SOCS3 in immune regulation of inflammatory bowel disease and cancer (2021) (2021)](https://doi.org/10.1016/j.pharmthera.2021.107854)

Pathway Diagram

The following diagram shows the key molecular relationships involving SOCS3 - Suppressor of Cytokine Signaling 3 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SOCS3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-socs3
kg_node_id	SOCS3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-f96839aa8988
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-socs3'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

26

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SOCS3 - Suppressor of Cytokine Signaling 3

SOCS3 - Suppressor of Cytokine Signaling 3

Overview

SOCS3 - Suppressor of Cytokine Signaling 3

Overview

Gene Structure and Expression

Protein Function and Mechanism

Domain Architecture

Mechanism of JAK-STAT Inhibition

Specificity and Selectivity

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

ALS

Axonal Regeneration (Double-Edged Sword)

Common Variants

Therapeutic Implications

Restoring SOCS3 in Neurodegeneration

SOCS3 Inhibition for Regeneration

Biomarker Applications

Expression Profile

See Also

External Links

References

Pathway Diagram

💬 Discussion